Back
Travere Therapeutics Vs. Smith-Midland Industry Stock Comparison
Sell
46
TVTX
Travere Therapeutics
Last Price:
14.6000
Seasonality Move:
-3.64%
Buy
53
SMID
Smith-Midland
Last Price:
37.15
Seasonality Move:
6.8%
Sell
46
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $14.3500. The Score for TVTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Smith-Midland (SMID)
is a Buy
Is Smith-Midland a Buy, Sell or Hold?
- The current Smith-Midland [SMID] share price is $36.83. The Score for SMID is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SMID is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $14.3500
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
SMID Stock Price Chart
What is Smith-Midland's stock price today?
-
The Smith-Midland share price today is $36.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMID is experiencing slight buying pressure.
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 81.71 | Buy |
| Chaikin Money Flow: | -283206 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.4864 - 12.6064) | Buy |
| Bollinger Bands (100): | (6.5785 - 10.4785) | Buy |
SMID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 15449 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.89 - 35.25) | Buy |
| Bollinger Bands (100): | (29.7 - 36.08) | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.38 | Buy |
| 20-day SMA: | 10.99 | Buy |
| 50-day SMA: | 9.99 | Buy |
| 200-day SMA: | 8.29 | Buy |
| 8-day EMA: | 13.25 | Buy |
| 20-day EMA: | 11.68 | Buy |
| 50-day EMA: | 10.19 | Buy |
| 200-day EMA: | 9.35 | Buy |
SMID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.66 | Buy |
| 20-day SMA: | 33.36 | Buy |
| 50-day SMA: | 32.03 | Buy |
| 200-day SMA: | 36.42 | Buy |
| 8-day EMA: | 34.51 | Buy |
| 20-day EMA: | 33.32 | Buy |
| 50-day EMA: | 32.69 | Buy |
| 200-day EMA: | 32.82 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.36 per share, a decrease this year of $2.18 per share, and an increase next year of $2.31 per share.
Smith-Midland Earnings Growth & SMID Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Smith-Midland Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||